Pre-treatment with LCZ696, an orally active angiotensin receptor neprilysin inhibitor, prevents ischemic brain damage
Hui‐Yu Bai(Ehime University), Masatsugu Horiuchi(Ehime University), Jun Iwanami(Ehime University), Akinori Higaki(Ehime University), Masayoshi Kukida(University of Kentucky), Kana Tsukuda(Ehime University), Bao‐Shuai Shan(Ehime University), Toshiyuki Chisaka(Ehime University), Xiaoli Wang(Shenyang Pharmaceutical University), Harumi Kan‐no(Ehime University), Hirotomo Nakaoka(Ehime University), Toshifumi Yamauchi(Ehime University), Masaki Mogi(Ehime University)
Cited by 22
Related Papers
Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)
|Hypertension Research|2014|1.4k
The WHO Global report 2023 on hypertension warning the emerging hypertension burden in globe and its treatment strategy
|Hypertension Research|2024|341
Neuroprotective effects of puerarin against beta-amyloid-induced neurotoxicity in PC12 cells via a PI3K-dependent signaling pathway
|Brain Research Bulletin|2011|93
Resveratrol increase myocardial Nrf2 expression in type 2 diabetic rats and alleviate myocardial ischemia/reperfusion injury (MIRI)
|Annals of Palliative Medicine|2019|83
Allelic loss of chromosome 13q14.3 in human oral cancer: Correlation with lymph node metastasis
|International Journal of Cancer|1998|71